Pfizer's Smoking Cessation Therapy Now Available
Filed in archive Drugs, Vaccines and Therapeutics on August 2, 2006
Nearly three months after it has been approved by the US Food and Drug Administration, Pfizer's smoking cessation drug, Chantix, is now available in US pharmacies.
Chantix (varenicline) works by binding to nicotine-receptors in the brain, thus blocking inhaled nicotine. The drug, at 1 mg twice a day, is available with prescription, and may not be covered by most HMO policies. According to this report, the average wholesale price of the drug is $3.20 per day, which works out to about $269 for the 12-week treatment regimen.
Patients prescribed with Chantix may also participate in a behavioral modification program developed by Pfizer, called GETQUITâ„¢ Support Plan, at no additional cost.
More details from Pfizer's press release.
Tags: smoking nicotine biotech pfizer available smoking+cessation pfizer+smoking therapy+available
Vote for Pfizer's Smoking Cessation Therapy Now Available:
|
Rating: 6.80 out of 5 vote(s) cast.
|
Response from:
Trusted.MD Network
Hey, if I told you about considering Chantix to quit smoking, forget about it.
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells